Relmada Therapeutics Inc. (RLMD)
Market Open
12 Jun, 13:56
$
6. 66
+0.14
+2.1626%
$
436.34M Market Cap
- P/E Ratio
- Div Yield
28,910 Volume
- Eps
$ 6.52
Previous Close Want to track RLMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Relmada Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 504,820 | $3.11M | $3.31M | $197,185.04 | 6.33% |
| RO Regan O'Neill Burkehill Global Management LP | 105,263 | $732,630.48 | $695,788.43 | -$36,842.05 | -5.03% |
| JJC Joseph J. Costigan apricus wealth LLC | 47,462 | $340,785.35 | $309,452.24 | -$31,333.11 | -9.19% |
| KJ Ken Joseph Braidwel LLP | 1.58M | $7.64M | $10.38M | $2.74M | 35.82% |
| KR Kevin Roan Stempoint Capita LLP | 597,409 | $4.16M | $3.92M | -$238,963.96 | -5.75% |
 Christopher C. Powers Farther Finance Advisors, LLC | 684 | $1,374.53 | $4,459.68 | $3,085.15 | 224.45% |
 Ian Jameson American Capital Advisory, LLC | 1,954 | $528 | $12,740.08 | $12,212.08 | 2,312.89% |
| SAG Stephen A. Greco Pandora Wealth Inc. | 20,000 | $5,400 | $132,400 | $127,000 | 2,351.85% |
| YML Yuen Man Lee Persistent Asset Partners Ltd. | 231,123 | $1.12M | $1.52M | $402,154.11 | 36.02% |
